Now showing items 1-1 of 1

    • NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma 

      Galipeau, Patricia C; Li, Xiaohong; Blount, Patricia L; Maley, Carlo C; Sanchez, Carissa A; Odze, Robert D.; Ayub, Kamran; Rabinovitch, Peter S; Vaughan, Thomas L; Reid, Brian J (Public Library of Science, 2007)
      Background: Somatic genetic CDKN2A, TP53, and DNA content abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma (EA) and Barrett's esophagus (BE), conditions for which ...